atorvastatin has been researched along with Neuralgia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balaganur, V; Kant, V; Kumar, D; Lingaraju, MC; More, AS; Pathak, NN; Tandan, SK | 1 |
Gillon, JT; Lowden, MR; Smith, SE | 1 |
Balaganur, V; Kant, V; Kumar, D; Latief, N; Lingaraju, MC; More, AS; Pathak, NN; Tandan, SK | 1 |
Chen, JY; Chu, LW; Wu, BN; Wu, PC | 1 |
4 other study(ies) available for atorvastatin and Neuralgia
Article | Year |
---|---|
Antihyperalgesic and anti-inflammatory effects of atorvastatin in chronic constriction injury-induced neuropathic pain in rats.
Topics: Analgesia; Animals; Anti-Inflammatory Agents; Atorvastatin; Constriction; Dinoprostone; Disease Models, Animal; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-1beta; Male; Matrix Metalloproteinase 2; Nerve Growth Factor; Neuralgia; Pain Measurement; Pyrroles; Rats; Rats, Wistar; Sciatic Nerve; Spinal Cord; Tumor Necrosis Factor-alpha | 2013 |
Atorvastatin as novel treatment for neuropathic pain: a case report.
Topics: Analgesics; Atorvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Neuralgia; Phantom Limb; Pyrroles; Treatment Outcome | 2013 |
Atorvastatin attenuates neuropathic pain in rat neuropathy model by down-regulating oxidative damage at peripheral, spinal and supraspinal levels.
Topics: Animals; Antioxidants; Atorvastatin; Down-Regulation; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperalgesia; Male; Neuralgia; Oxidative Stress; Pyrroles; Rats, Wistar; Sciatic Nerve; Spinal Cord | 2014 |
Atorvastatin prevents neuroinflammation in chronic constriction injury rats through nuclear NFκB downregulation in the dorsal root ganglion and spinal cord.
Topics: Animals; Anti-Inflammatory Agents; Atorvastatin; Cell Nucleus; Chronic Disease; Constriction, Pathologic; Disease Models, Animal; Down-Regulation; Ganglia, Spinal; Hyperalgesia; Male; Microglia; Neuralgia; Neuroimmunomodulation; NF-kappa B; Rats, Sprague-Dawley; Spinal Cord; Time Factors; Treatment Outcome | 2015 |